Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gucci

This article was originally published in The Rose Sheet

Executive Summary

New YSL fragrance bowing in fall 2001 expected to lead to high single-digit revenue increase at YSL Beaute next year, company reports Dec. 14. YSL Beaute cosmetics revenue increased 3.3% to $34.9 mil. in third quarter due to "strong makeup sales." Cosmetics were sole bright spot, however, as all other YSL Beaute segments saw double-digit decreases. Fragrance sales were down 16.7% to $75.8 mil. in the period; overall YSL Beaute revenue fell 13.4% to $161.9 mil. Gucci attributes declines to Euro depreciation. Except for cosmetics, which jumped 11.2% to $106.1 mil. nine-month performances also were down throughout the Gucci Group division
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS008764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel